Toggle navigation
Login
Toggle navigation
JavaScript is disabled for your browser. Some features of this site may not work without it.
Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy
QMRO Home
Wolfson Institute of Preventive Medicine
Centre for Preventative Neurology
Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy
QMRO Home
Wolfson Institute of Preventive Medicine
Centre for Preventative Neurology
Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy
Browse
All of QMRO
Communities & Collections
By Issue Date
Authors
Titles
Subjects
This Collection
By Issue Date
Authors
Titles
Subjects
Administrators only
Login
Statistics
Most Popular Items
Statistics by Country
Most Popular Authors